Solventum (FRA:KB7) Other Current Receivables: €105 Mil (As of Mar. 2026)


FRA:KB7 Solventum Corp FRA:KB7
26 GF Score
Price €65.00
! 6 Warning Signs
View Full Analysis

What is Solventum Other Current Receivables?

Solventum FRA:KB7 -2.99% 26 Other Current Receivables is €105 Mil as of Mar. 2026. GuruFocus rates FRA:KB7 with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Solventum's Other Current Receivables for the quarter that ended in Mar. 2026 was €105 Mil.

Solventum's quarterly Other Current Receivables declined from Sep. 2025 (€133.76 Mil) to Dec. 2025 (€128.10 Mil) but then stayed the same from Dec. 2025 (€128.10 Mil) to Mar. 2026 (€104.67 Mil).

Solventum's annual Other Current Receivables increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€176.68 Mil) but then declined from Dec. 2024 (€176.68 Mil) to Dec. 2025 (€128.10 Mil).

Solventum Other Current Receivables Related Terms

Solventum Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Solventum's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum Other Current Receivables Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.00 0.00 0.00 176.68 128.10

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.13 164.73 133.76 128.10 104.67
FRA:KB7
26GF Score
Solventum Corp FRA:KB7
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solventum Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €105 Mil mean?
Solventum (FRA:KB7) has a Other Current Receivables of €105 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Solventum and its competitors.
Is Solventum's Other Current Receivables too high?
Solventum's current Other Current Receivables is €105 Mil. Overall, Solventum has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Other Current Receivables compare to COO and ALGN?
Solventum's Other Current Receivables of €105 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Solventum and its competitors. Solventum's current Other Current Receivables is €105 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (FRA:KB7) has a current Other Current Receivables of €105 Mil. The current Other Current Receivables is €105 Mil. Solventum's overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Solventum (FRA:KB7), the current Other Current Receivables is €105 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solventum Business Description

Address 2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
26GF Score

Get the complete analysis for FRA:KB7

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price